BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 37129928)

  • 1. Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy.
    Leali M; Aimo A; Ricci G; Torri F; Todiere G; Vergaro G; Grigoratos C; Giannoni A; Aquaro GD; Siciliano G; Emdin M; Passino C; Barison A
    J Cardiovasc Med (Hagerstown); 2023 Jun; 24(6):340-347. PubMed ID: 37129928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Involvement in Myotonic Dystrophy Type 2 Patients With Preserved Ejection Fraction: Detection by Cardiovascular Magnetic Resonance.
    Schmacht L; Traber J; Grieben U; Utz W; Dieringer MA; Kellman P; Blaszczyk E; von Knobelsdorff-Brenkenhoff F; Spuler S; Schulz-Menger J
    Circ Cardiovasc Imaging; 2016 Jul; 9(7):. PubMed ID: 27363857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality.
    Cardona A; Arnold WD; Kissel JT; Raman SV; Zareba KM
    J Cardiovasc Magn Reson; 2019 May; 21(1):26. PubMed ID: 31046780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study.
    Blaszczyk E; Lim C; Kellman P; Schmacht L; Gröschel J; Spuler S; Schulz-Menger J
    J Cardiovasc Magn Reson; 2021 Nov; 23(1):130. PubMed ID: 34743704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement.
    Lang SM; Alsaied T; Khoury PR; Ryan TD; Taylor MD
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):635-642. PubMed ID: 32951096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Right Ventricular Function in Patients With Suspected Myocarditis Undergoing Cardiac Magnetic Resonance.
    Bernhard B; Schnyder A; Garachemani D; Fischer K; Tanner G; Safarkhanlo Y; Stark AW; Schütze J; Pavlicek-Bahlo M; Greulich S; Johner C; Wahl A; Benz DC; Kwong RY; Gräni C
    JACC Cardiovasc Imaging; 2023 Jan; 16(1):28-41. PubMed ID: 36599567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and prognostic significance of left ventricular myocardial late gadolinium enhancement in severe aortic stenosis.
    Rajesh GN; Thottian JJ; Subramaniam G; Desabandhu V; Sajeev CG; Krishnan MN
    Indian Heart J; 2017; 69(6):742-750. PubMed ID: 29174252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study.
    Petri H; Ahtarovski KA; Vejlstrup N; Vissing J; Witting N; Køber L; Bundgaard H
    J Cardiovasc Magn Reson; 2014 Aug; 16(1):59. PubMed ID: 25086734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1.
    Chmielewski L; Bietenbeck M; Patrascu A; Rösch S; Sechtem U; Yilmaz A; Florian AR
    Clin Res Cardiol; 2019 Aug; 108(8):857-867. PubMed ID: 30767060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and electrical cardiac abnormalities are prevalent in asymptomatic adults with myotonic dystrophy.
    Choudhary P; Nandakumar R; Greig H; Broadhurst P; Dean J; Puranik R; Celermajer DS; Hillis GS
    Heart; 2016 Sep; 102(18):1472-8. PubMed ID: 27164920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclinical myocardial injury in patients with Facioscapulohumeral muscular dystrophy 1 and preserved ejection fraction - assessment by cardiovascular magnetic resonance.
    Blaszczyk E; Grieben U; von Knobelsdorff-Brenkenhoff F; Kellman P; Schmacht L; Funk S; Spuler S; Schulz-Menger J
    J Cardiovasc Magn Reson; 2019 Apr; 21(1):25. PubMed ID: 31030674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between right ventricular T
    Jellis CL; Yingchoncharoen T; Gai N; Kusunose K; Popović ZB; Flamm S; Kwon D
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):55-65. PubMed ID: 28357724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CMR T
    Zhao P; Huang L; Ran L; Tang D; Zhou X; Xia L
    Eur Radiol; 2021 Mar; 31(3):1206-1215. PubMed ID: 32876836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular magnetic resonance imaging characteristics and influence factors of aortic insufficiency patients with myocardial fibrosis].
    Zheng YC; Lu MJ; Chen XY; Yang K; Yin G; Wang K; Zhao SH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Aug; 47(8):622-627. PubMed ID: 31434433
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic Value of Late Gadolinium Enhancement Detected on Cardiac Magnetic Resonance in Cardiac Sarcoidosis.
    Stevenson A; Bray JJH; Tregidgo L; Ahmad M; Sharma A; Ng A; Siddiqui A; Khalid AA; Hylton K; Ionescu A; Providencia R; Kirresh A
    JACC Cardiovasc Imaging; 2023 Mar; 16(3):345-357. PubMed ID: 36752432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.
    Pöyhönen P; Kivistö S; Holmström M; Hänninen H
    BMC Cardiovasc Disord; 2014 Aug; 14():110. PubMed ID: 25160650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular geometric remodeling in relation to non-ischemic scar pattern on cardiac magnetic resonance imaging.
    Kim J; Kochav JD; Gurevich S; Afroz A; Petashnick M; Volo S; Diaz B; Okin PM; Horn E; Devereux RB; Weinsaft JW
    Int J Cardiovasc Imaging; 2014 Dec; 30(8):1559-67. PubMed ID: 25008088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Cardiac Magnetic Resonance Markers of Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy for Predicting Heart Failure Outcomes.
    Chun KH; Oh J; Hong YJ; Yu HT; Lee CJ; Kim TH; Joung B; Pak HN; Lee MH; Kim YJ; Kang SM
    J Am Heart Assoc; 2022 Mar; 11(6):e023167. PubMed ID: 35261277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.